Novo Nordisk’s journey to an R-based FDA submission

This is a companion discussion topic for the original entry at https://posit.co/blog/novo-nordisks-journey-to-an-r-based-fda-submission

This topic was automatically closed after 59 days. New replies are no longer allowed.


If you have a query related to it or one of the replies, start a new topic and refer back with a link.